HOXD9 and ovarian cancer: Using quantitative PCR with reverse transcription (RT–qPCR) analysis we quantified expression of HOXD9, CDC42 and CDCA8 in ovarian cancer cell lines (N=14) and ovarian (N=6) and fallopian (N=3) epithelial cells (Fig. 1b).